Published in Psychiatr Serv on July 01, 2007
Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med (2010) 4.42
Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophr Res (2012) 1.56
Revisiting practice-based research networks as a platform for mental health services research. Adm Policy Ment Health (2009) 1.12
Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice. Psychiatr Clin North Am (2012) 1.04
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia. BMC Psychiatry (2009) 0.93
Antipsychotic polypharmacy in a regional health service: a population-based study. BMC Psychiatry (2012) 0.84
Roles in and barriers to metabolic screening for people taking antipsychotic medications: a survey of psychiatrists. Schizophr Res (2012) 0.83
Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment. Int J Neuropsychopharmacol (2013) 0.81
Evaluation of different approaches for confounding in nonrandomised observational data: a case-study of antipsychotics treatment. Community Ment Health J (2014) 0.79
Predictors of long-term (≥6months) antipsychotic polypharmacy prescribing in secondary mental healthcare. Schizophr Res (2016) 0.76
Adding and switching antipsychotics. Psychiatr Serv (2007) 0.75
Concomitant use of two or more antipsychotic drugs is common in Sweden. Ther Adv Psychopharmacol (2015) 0.75
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry (1988) 12.39
The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophr Bull (2004) 7.58
Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry (2004) 6.40
Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ (1993) 5.37
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry (2002) 5.14
Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N Engl J Med (2006) 4.16
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry (2006) 4.12
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry (2004) 3.76
A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. N Engl J Med (1997) 3.12
Management of treatment resistance in schizophrenia. Biol Psychiatry (2001) 2.20
Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatr Scand (2002) 2.00
Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study. Br J Psychiatry (1997) 1.93
Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region. Schizophr Bull (2002) 1.68
Treatment-resistant schizophrenia--the role of clozapine. Curr Med Res Opin (1997) 1.64
Olanzapine treatment of residual positive and negative symptoms. Am J Psychiatry (2005) 1.57
Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am J Psychiatry (1998) 1.51
Selected characteristics and data of psychiatrists in the United States, 2001-2002. Acad Psychiatry (2003) 1.45
Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: individual and facility predictors. Med Care (2001) 1.42
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry (2004) 1.35
A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Curr Med Chem (2004) 1.35
Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study. Psychopharmacology (Berl) (2003) 1.34
Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry (2005) 1.31
Evaluation of treatment-resistant schizophrenia. Schizophr Bull (1997) 1.31
A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety. J Clin Psychiatry (2005) 1.31
Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry (2004) 1.27
Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. Am J Psychiatry (1998) 1.27
Characterizing psychiatry with findings from the 1996 National Survey of Psychiatric Practice. Am J Psychiatry (1998) 1.10
Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia. J Clin Psychiatry (2003) 1.10
Comparison of clozapine use in Maryland and in Victoria, Australia. Psychiatr Serv (2005) 1.05
Clozapine in China: a review and preview of US/PRC collaboration. Psychopharmacology (Berl) (1989) 0.93
Use of combinations of antipsychotics: McLean Hospital inpatients, 2002. Hum Psychopharmacol (2005) 0.92
Sex differences in the subjective tolerability of antipsychotic drugs. J Clin Psychopharmacol (2005) 0.89
What is relapse in schizophrenia? Int Clin Psychopharmacol (1995) 0.87
Clozapine eligibility among state hospital patients. Schizophr Bull (1996) 0.86
A simple switching strategy for inadequately treated patients with schizophrenia to olanzapine: changes in psychopathology and subjective well-being. Pharmacopsychiatry (2005) 0.81
Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 13.63
Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med (2005) 8.52
National trends in the outpatient treatment of depression. JAMA (2002) 7.09
Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 6.03
Issues in the registration of clinical trials. JAMA (2007) 5.92
The most expensive medical conditions in America. Health Aff (Millwood) (2002) 5.50
National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry (2007) 5.49
National patterns in antidepressant medication treatment. Arch Gen Psychiatry (2009) 4.82
Sudden death and use of stimulant medications in youths. Am J Psychiatry (2009) 4.33
Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry (2002) 3.71
Changing profiles of service sectors used for mental health care in the United States. Am J Psychiatry (2006) 3.64
Trends in mental health care among children and adolescents. N Engl J Med (2015) 3.54
Mental health of college students and their non-college-attending peers: results from the National Epidemiologic Study on Alcohol and Related Conditions. Arch Gen Psychiatry (2008) 3.52
Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry (2006) 3.50
Trends in care by nonphysician clinicians in the United States. N Engl J Med (2003) 3.24
Retractions in the research literature: misconduct or mistakes? Med J Aust (2006) 3.17
Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry (2008) 3.15
Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry (2010) 3.14
National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry (2003) 3.07
A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry (2004) 3.00
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry (2008) 2.86
Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care (2011) 2.81
Interventions to improve medication adherence in schizophrenia. Am J Psychiatry (2002) 2.78
National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry (2012) 2.52
Declining use of electroconvulsive therapy in United States general hospitals. Biol Psychiatry (2012) 2.50
Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry (2003) 2.40
Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood) (2003) 2.37
Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics (2008) 2.32
Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff (Millwood) (2009) 2.29
National trends in outpatient psychotherapy. Am J Psychiatry (2010) 2.24
Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry (2004) 2.24
National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry (2002) 2.22
Comparison of objective and patient-reported hot flash measures in men with prostate cancer. J Support Oncol (2009) 2.20
Major depression in community-dwelling middle-aged and older adults: prevalence and 2- and 4-year follow-up symptoms. Psychol Med (2004) 2.02
National trends in psychotherapy by office-based psychiatrists. Arch Gen Psychiatry (2008) 1.99
National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry (2010) 1.99
Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry (2013) 1.95
Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study. Arch Gen Psychiatry (2006) 1.93
National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry (2010) 1.93
National trends in ethnic disparities in mental health care. Med Care (2007) 1.91
Training and consultation to promote implementation of an empirically supported treatment: a randomized trial. Psychiatr Serv (2012) 1.87
Parental depression, child mental health problems, and health care utilization. Med Care (2003) 1.86
National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. J Am Acad Child Adolesc Psychiatry (2010) 1.84
National trends in hospitalization of youth with intentional self-inflicted injuries. Am J Psychiatry (2005) 1.80
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2011) 1.80
National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. Am J Psychiatry (2011) 1.79
Decline in placebo-controlled trial results suggests new directions for comparative effectiveness research. Health Aff (Millwood) (2013) 1.76
Medication use in US youth with mental disorders. JAMA Pediatr (2013) 1.75
Hyperlipidemia following treatment with antipsychotic medications. Am J Psychiatry (2006) 1.74
Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Arch Gen Psychiatry (2008) 1.73
Screening for bipolar disorder in a primary care practice. JAMA (2005) 1.72
Access to psychiatrists in the public sector and in managed health plans. Psychiatr Serv (2005) 1.71
The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology (2006) 1.71
National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. J Clin Psychiatry (2008) 1.69
Depression in US Hispanics: diagnostic and management considerations in family practice. J Am Board Fam Pract (2005) 1.69
Service implications of providing intensive monitoring during high-risk periods for suicide among VA patients with depression. Psychiatr Serv (2009) 1.68
Continuity of care after inpatient discharge of patients with schizophrenia in the Medicaid program: a retrospective longitudinal cohort analysis. J Clin Psychiatry (2010) 1.67
Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff (Millwood) (2011) 1.64
Depression in African Americans: breaking barriers to detection and treatment. J Fam Pract (2006) 1.60
National trends in the use of outpatient psychotherapy. Am J Psychiatry (2002) 1.59
Psychiatric opinion and antipsychotic selection in the management of schizophrenia. Psychiatr Serv (2008) 1.56
Evidence-based practice for acute low back pain in primary care: patient outcomes and cost of care. Pain (2006) 1.52
Delays in initial treatment contact after first onset of a mental disorder. Health Serv Res (2004) 1.50
Antipsychotic dosage at hospital discharge and outcomes among persons with schizophrenia. Psychiatr Serv (2003) 1.50
Growth and decentralization of the medical literature: implications for evidence-based medicine. J Med Libr Assoc (2005) 1.50
Length of stay of pediatric mental health emergency department visits in the United States. J Am Acad Child Adolesc Psychiatry (2011) 1.49
Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry (2007) 1.49
Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry (2002) 1.48
Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts. J Affect Disord (2008) 1.48
Tracking publication outcomes of National Institutes of Health grants. Am J Med (2005) 1.48
Emergency treatment of young people following deliberate self-harm. Arch Gen Psychiatry (2005) 1.47
Social anxiety disorder in primary care. Gen Hosp Psychiatry (2005) 1.46
Mental health screening of adolescents in pediatric practice. J Behav Health Serv Res (2011) 1.45
Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med (2005) 1.42
A systematic review of validated methods for identifying depression using administrative data. Pharmacoepidemiol Drug Saf (2012) 1.41
Characterizing Primary Care Visit Activities at Veterans Health Administration Clinics. J Healthc Manag (2015) 1.40
The role of treatment fidelity on outcomes during a randomized field trial of an autism intervention. Autism (2013) 1.38
Trends in the inpatient mental health treatment of children and adolescents in US community hospitals between 1990 and 2000. Arch Gen Psychiatry (2007) 1.37
Medical services for clients in community mental health centers: results from a national survey. Psychiatr Serv (2008) 1.37
Child physical abuse and adult mental health: a national study. J Trauma Stress (2012) 1.33
Outpatient antipsychotic treatment and inpatient costs of schizophrenia. Schizophr Bull (2007) 1.30
Challenges in increasing access to buprenorphine treatment for opiate addiction. Am J Addict (2004) 1.29
National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey. J Clin Psychiatry (2014) 1.29
Posttraumatic stress disorder in primary care one year after the 9/11 attacks. Gen Hosp Psychiatry (2006) 1.28
Outpatient treatment of child and adolescent depression in the United States. Arch Gen Psychiatry (2003) 1.28
Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med (2005) 1.26
Generalizability of clinical trials for alcohol dependence to community samples. Drug Alcohol Depend (2008) 1.25
National trends in nonoperative care for nonspecific back pain. Spine J (2004) 1.24
Datapoints: trends by race and gender in suicide attempts among U.S. adolescents, 1991-2001. Psychiatr Serv (2003) 1.22
Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study. BMJ (2012) 1.22
Implications of childhood autism for parental employment and earnings. Pediatrics (2012) 1.22